Table 3.
The severity of the symptoms | Saffron group (%) | Fluoxetine group (%) | Placebo group (%) | P | Test |
---|---|---|---|---|---|
DRSP before the interventions | |||||
Mild (0-33) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0.006 | χ2 |
Moderate (33-66) | 33 (82.5) | 27 (67.5) | 38 (95.0) | ||
Severe (>66) | 7 (17.5) | 13 (32.5) | 2 (5.0) | ||
DRSP after the interventions | |||||
Mild (0-33) | 25 (67.6) | 15 (41.7) | 19 (54.3) | 0.18 | Fisher’s exact test |
Moderate (33-66) | 11 (29.7) | 20 (55.6) | 15 (42.9) | ||
Severe (>66) | 1 (2.7) | 1 (2.8) | 1 (2.9) | ||
Hamilton score before intervention | |||||
Regular (0-7) | 2 (5.0) | 1 (2.5) | 0 (0.0) | 0.77 | Fisher’s exact test |
Severe (8-14) | 38 (95.0) | 39 (97.5) | 40 (100.0) | ||
Hamilton score after interventions | |||||
Regular (0-7) | 29 (78.4) | 21 (58.3) | 22 (62.9) | 0.16 | χ2 |
Severe (8-14) | 8 (21.6) | 15 (41.7) | 13 (37.1) |
DRSP: Daily record of severity of problems